AMEL (Private limited company)
AMEL is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0449.953.801. It was founded on 31-03-1993. Its registered office is in Ixelles. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 23 953 and a loss of € 102 151. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 07-10-2026.
Company information
Key figures of AMEL
| 2025 | 2024 | 2023 | |
|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -102 151-177 % | € -36 942 | € 133 695 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 23 953-81 % | € 126 104-23 % | € 163 046 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 2 799 138+13 % | € 2 468 230+129 % | € 1 079 629 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 54 341+10 % | € 49 593-77 % | € 216 440 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - | - | - |
Financial estimate
Similar companies
Other companies in the same activity in Ixelles.
| Company | Town |
|---|---|
| Pfizer | 1050 Ixelles |
| Besins Manufacturing Belgium | 1050 Ixelles |
| Collabor - Buro Intérim | 1050 Ixelles |
| Belphar | 1050 Ixelles |
| Limea | 1050 Ixelles |
| Withers en Gerke (Europa) | 1050 Ixelles |
| Progeco | 1050 Bruxelles |
| International Design Company (I.D.C.) | 1050 Ixelles |
Frequently asked questions
Is AMEL still active? Yes. The Crossroads Bank for Enterprises lists AMEL as active.
What is the VAT number of AMEL? AMEL is not registered for VAT. Its enterprise number is 0449.953.801.
When was AMEL founded? AMEL was founded on 31-03-1993.
What is the address of AMEL? The current registered office of AMEL is Avenue de l'Hippodrome 66, 1050 Ixelles.
When did AMEL last file annual accounts? The latest annual accounts of AMEL were filed on 28-08-2026.
Does AMEL file its annual accounts on time? Yes. AMEL filed its annual accounts within the legal deadline for each of its last 4 financial years.
Is AMEL financially healthy? Addrly gives AMEL a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is AMEL profitable? The annual accounts of AMEL for 2025 show a loss of € 102 151.
What is the equity of AMEL? The equity of AMEL was € 23 953 at the close of the 2025 financial year.
Who are the directors of AMEL? The annual accounts of AMEL record 3 mandates. The names, roles and dates are visible with a free account.
Can AMEL receive Peppol e-invoices? Yes. AMEL is registered on the Peppol network and can receive structured electronic invoices.
What does AMEL do? The main activity of AMEL is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.